(Q45843781)

English

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

0 references

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Peter Karayiannis

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

author name string

Brook MG

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

Thomas HC

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

language of work or name

0 references

publication date

1 November 1989

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

10

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

5

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

761-763

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

21 January 2018

Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

21 January 2018

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

21 January 2018

Pilot study of recombinant human alpha-interferon for chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoblastoid interferon therapy of chronic HBV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoblastoid and recombinant alpha-A interferon therapy of chronic hepatitis B virus infection. The Royal Free Hospital experience

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

A rapid one-step radiometric assay for hepatitis B surface antigen utilizing monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

The detection of HBV-DNA in serum by molecular hybridisation: a more sensitive method for the detection of complete HBV particles

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of cellular immunity to hepatitis-B-virus antigens from the early incubation phase of acute hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Strangulated Spigelian hernia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of factors predicting early seroconversion to anti-HBe in HBeAg-positive chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute exacerbation in chronic type B hepatitis: comparison between HBeAg and antibody-positive patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Integration of hepatitis B virus sequences and their expression in a human hepatoma cell

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

History of the American Association for the Study of Liver Diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

The detection of antibodies to recombinant interferon alfa-2a in human serum

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100502

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.1840100502

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2680866

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45843781&oldid=2086143314"